Lawrie, 1,107 patient ivermectin meta analysis: 83% lower mortality [p<0.0001] https://c19p.org/lawrie
copied to clipboard
Ivermectin reduces the risk of death from COVID-19 – a rapid review and meta-analysis in support of the recommendation of the Front Line COVID-19 Critical Care Alliance
et al., Preprint (Preprint) (meta analysis)
Meta analysis confirming the effectiveness of ivermectin for COVID-19, showing ivermectin treatment mortality relative risk RR 0.17 [0.18-0.35] and prophylaxis cases RR 0.12 [0.08-0.18].Currently there are
88 ivermectin
for COVID-19 studies, showing 51% [37‑62%] lower mortality, 31% [15‑45%] lower ventilation, 45% [22‑61%] lower ICU admission, 33% [20‑44%] lower hospitalization, and 78% [67‑86%] lower cases.
|
risk of death, 83.0% lower, RR 0.17, p < 0.001, treatment 8 of 585 (1.4%), control 44 of 522 (8.4%), NNT 14.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Lawrie et al., 1/3/2021, preprint, 1 author.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.